Monica Raimo

Company: Glycostem Therapeutics

Job title: Director - Product & Process Development

Seminars:

Harnessing Allogeneic NK Cells: Non-Engineered, Engineered, & Combination Approaches in Oncology & Autoimmune Disorders 1:15 pm

Clinical development of non-engineered NK cells in hematological malignancies Preclinical innovations in engineered and combination NK cell therapies for oncology and autoimmunityRead more

day: Day Two - Track A PM

Workshop B: Consistency & Control in Cell Phenotypes: Ensuring Reliable Expansion for Scalable Manufacturing 1:00 pm

As allogeneic developers prepare for pivotal scale-up, understanding how to maintain uniformity in cell characteristics becomes crucial. The workshop will explore the latest methodologies, technologies, and best practices for optimizing cell expansion processes. Join this workshop to:  Explore the complexities of achieving consistent cell phenotypes in the context of allogeneic therapies and understand the factors that contribute to variability Learn about…Read more

day: Pre-Conference Workshops - Track B PM

Panel Discussion: Understanding When & How to Implement Automation into the Process for a Seamless Transition into Automated Manufacturing 12:00 pm

Analyze the key factors that determine the optimal timing for integrating automation into manufacturing processes, focusing on efficiency, scalability, and cost-effectiveness Explore different automation technologies available for allogeneic cell manufacturing Discuss best practices for implementing automation, including staff training, system integration, and ongoing maintenanceRead more

day: Day One - Track B AM